@article{214f13fa13aa44f8a3ac65a1d221d200,
title = "Phenotype of PLP1-related Disorder Caused by Novel Mutation: A Case Report",
author = "Nikola Kresojevi{\'c} and Igor Petrovi{\'c} and Valerija Dobri{\v c}i{\'c} and Aleksandra Tomi{\'c} and Vesna Brankovi{\'c} and {Mili{\'c} Ra{\v s}i{\'c}}, Vedrana and Marina Svetel and Vladimir Kosti{\'c}",
note = "Funding Information: Ethical Compliance Statement: We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this work is consistent with those guidelines. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written consent to publish all shown materials was obtained from the patient in Serbian. Funding Sources and Conflicts of Interest: This study was supported by the Ministry of Education, Science, and Technological Development of the Republic of Serbia, project no. 175090 (to VK). The authors report no conflicts of interest. Financial Disclosures for previous 12 months: Nikola Kresojevi? is a member of advisory board of Univar BV. Igor Petrovi? has received speaker honoraria from Boehringer Ingelheim, GSK, El Pharma, Roche, and Actavis. Valerija Dobri?i?, Aleksandra Tomi?, Vesna Brankovi? and Vedrana Mili? Ra?i?: report no sources of funding and no conflicts of interest. Marina Svetel has received speaker's honoraria from Actavis. Vladimir Kosti? has received research grants from the Ministry of Education, Science, and Technological Development, Republic of Serbia and the Serbian Academy of Science and Arts; and speaker honoraria from Actavis and Salveo. Funding Information: Funding Sources and Conflicts of Interest: This study was supported by the Ministry of Education, Science, and Technological Development of the Republic of Serbia, project no. 175090 (to VK). The authors report no conflicts of interest. Funding Information: Financial Disclosures for previous 12 months: Nikola Kresojevi{\'c}is a member of advisory board of Univar BV. Igor Pet-rovi{\'c}has received speaker honoraria from Boehringer Ingelheim, GSK, El Pharma, Roche, and Actavis. Valerija Dobri≤ci{\'c}, Aleksandra Tomi{\'c}, Vesna Brankovi{\'c}and Vedrana Mili{\'c}Ra{\v s}i{\'c}: report no sources of funding and no conflicts of interest. Marina Svetel has received speaker{\textquoteright}s honoraria from Actavis. Vladimir Kosti{\'c}has received research grants from the Ministry of Education, Science, and Technological Development, Republic of Serbia and the Serbian Academy of Science and Arts; and speaker honoraria from Actavis and Salveo.",
year = "2018",
month = sep,
day = "1",
doi = "10.1002/mdc3.12644",
language = "English",
volume = "5",
pages = "548--550",
journal = "Movement Disorders Clinical Practice",
issn = "2330-1619",
number = "5",
}
